SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barriere, C., Stuckey, J.A., Meagher, J.L., Bai, L., Liu, L., Hoffman-Luca, C.G., Lu, J., Shangary, S., Yu, S., Bernard, D., Aguilar, A., Dos-Santos, O., Besret, L., Guerif, S., Pannier, P., Gorge-Bernat, D., Debussche, L.(2014) Cancer Res 74: 5855-5865
- PubMed: 25145672 
- DOI: 10.1158/0008-5472.CAN-14-0799
- Primary Citation of Related Structures:  
5TRF - PubMed Abstract: 
Blocking the oncoprotein murine double minute 2 (MDM2)-p53 protein-protein interaction has long been considered to offer a broad cancer therapeutic strategy, despite the potential risks of selecting tumors harboring p53 mutations that escape MDM2 con ...